About

Nick Smalley, Vice-President, Regulatory Affairs, has more than 25 years’ experience in pharmaceuticals and contract manufacturing and now leads Kindeva’s advanced drug delivery regulatory affairs function. After starting his career in inhalation research and development working on both pMDIs and DPIs, Mr Smalley moved into regulatory affairs in 1999 and has worked globally across multiple different product areas, including complex generics, biologics, consumer healthcare, medical devices and ethical pharmaceuticals.

He is also the Vice-Chair of the board of directors of the International Pharmaceutical Aerosol Consortium, a coalition of eight multinational pharmaceutical companies that strives to ensure global environmental policies that are relevant to inhaled therapies are patient-centric and appropriately balance patient care and sustainability efforts.
Mr Smalley hasa BSc in Chemistry from Loughborough University (UK).